Biography
BS (honors) University of Iowa
MS University of Iowa
PhD University of San Jose
DO Des Moines University, residency University of Iowa, Fellowship Harvard University (genetics)
MD Montserrat Medical School, Post doc Oxford University Evidence Based Medicine
Degrees
- M.D. medicine
- Montserrat College of Medicine, St. John, Montserrat
- Ph.D. Cell Biology
- University of San Jose, Costa Rica
- The Effect of Risperidone on Human Glia
- D.O. Medicine
- Des Moines University, Des Moines, Iowa, United States
Awards
- Fellow
- Royal Society of Medicine, Fall 2017
- American Neurological Association, Winter 2015
Licensure & Certification
- Diplomate, American Board of Psychiatry & Neurology (1987)
Interests
Research
Neurodegenerative diseasespsychosisgenetics
Teaching
neuropathologyschizophreniaDepression
Courses
No activities entered.
Scholarly Contributions
Chapters
- Wilcox, J. (2015). Catatonia, a 100 Year Cohort. In Catatonia on the Consultation Liaison Service and Other Clinical Settings. Hauppauge, New York: Nova Publishing.
Journals/Publications
- Wilcox, J. (2016). Is it a 'senior moment' or early dementia? Addressing memory concerns in older patients. Current Psychiatry, 15(5), 28-40.
- Wilcox, J. A., & Reid Duffy, P. (2015). The Syndrome of Catatonia. Behavioral sciences (Basel, Switzerland), 5(4), 576-88.More infoCatatonia is a psychomotor syndrome which has historically been associated with schizophrenia. Many clinicians have thought that the prevalence of this condition has been decreasing over the past few decades. This review reminds clinicians that catatonia is not exclusively associated with schizophrenia, and is still common in clinical practice. Many cases are related to affective disorders or are of an idiopathic nature. The illusion of reduced prevalence has been due to evolving diagnostic systems that failed to capture catatonic syndromes. This systemic error has remained unchallenged, and potentiated by the failure to perform adequate neurological evaluations and catatonia screening exams on psychiatric patients. We find that current data supports catatonic syndromes are still common, often severe and of modern clinical importance. Effective treatment is relatively easy and can greatly reduce organ failure associated with prolonged psychomotor symptoms. Prompt identification and treatment can produce a robust improvement in most cases. The ongoing prevalence of this syndrome requires that psychiatrists recognize catatonia and its presentations, the range of associated etiologies, and the import of timely treatment.
